IBD and Metabolic Bone disease in Beaumont hospital
Ashraf Monged, Conan Reilly, Jun Chin Liong, Dr Aobhlinn O'Toole
Beaumont Hospital, Gastroenterology Department
Patients with Inflammatory Bowel Disease (IBD) are at an increased risk of osteoporosis.The BSG guidelines recommend measuring bone mineral density (BMD) with Dualenergy X-ray absorptiometry (DEXA) in all patients under the age of 65 years who are exposed to corticosteroids for more than 3 months(1). Contributing factors include chronic inflammation, corticosteroid treatment, extensive small bowel disease or resection, age, smoking, low physical activity and nutritional deficiencies.(2)
The aim of this study is to present the prevalence of osteoporosis and osteopenia among IBD patient’s in Beaumont hospital.
A list of Beaumont Hospital Gastroenterology patients who had DEXA scans performed in the past 9 months (January- September 2015) was generated. Patients with a diagnosis of IBD from colonoscopy reports on ENDORAAD software were selected. Patient age, sex, diagnosis and dexa results were collected and analysed.
Ulcerative colitis DEXA Normal Osteopenic Osteoporosis Total 5 12 1 18 Gender M/F 1M/4F 6M/6F 1M/0 Age below 50/above 50 4(F)/ 1(M) 8(5M,3F)/4(1M, 3F) 0/1(M) Crohn’s disease DEXA Normal Osteopenic Osteoporosis Total 9 9 5 24 Gender M/F 4M/5F 7M/2F 2M/3F Age below 50/above 50 8(3M, 5F) /1(M) 6(2M,4F) /3(3F) 1(1F)/4(2M, 2F) Osteoporosis is more common in patient s with ulcerative colitis, rather than with Crohn’s disease. The majority of patients diagnosed with osteoporosis are over the age of 50.
More than 50% of patients had abnormal DEXAs and we need to strive to identify risk factors.